Sangita Shah
Corporate Officer/Principal bij PreEmptive Meds, Inc.
Vermogen: 67 452 $ op 31-03-2024
Profiel
Sangita Shah currently works in finance and accounting at PreEmptive Meds, Inc. and currently holds a managerial position in the same field at the same company.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
FORWARD INDUSTRIES INC.
1.10% | 22-12-2023 | 111 123 ( 1.10% ) | 67 452 $ | 31-03-2024 |
Actieve functies van Sangita Shah
| Bedrijven | Functie | Begin |
|---|---|---|
PreEmptive Meds, Inc.
 PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
PreEmptive Meds, Inc.
PreEmptive Meds, Inc. BiotechnologyHealth Technology PreEmptive Meds, Inc. develops and sales therapeutic nutraceuticals. Its all-natural, plant based formulations have been clinically proven to be safe and effective by hundreds of primary care physicians who have used its products in thousands of patients. The company was founded by Charles N. Blitzer and Joe Fenn in 2006 and is headquartered in Lebanon, NJ. | Health Technology |
